h-header

news

News dal mondo

22

Set

AstraZeneca Plans New API Manufacturing Facility in Ireland

AstraZeneca said it plans to establish an active pharmaceutical ingredient (API) manufacturing plant for small molecules in Ireland.

The goal of the $360 million investment is to reduce time to drug commercialization, lower costs and enable more sustainable manufacturing processes, the Anglo-Swedish drugmaker said.

The APIs will include “compounds with highly complex synthesis, requiring next-generation technologies and capabilities that can respond quickly and nimbly to rapidly changing clinical and commercial needs,” said Pam Cheng, the company’s executive vice president of global operations and IT

[FDANews]

03

Dic

AIFA - Agenzia Industrie Difesa: firmato accordo quadro di collaborazione

Il rinnovato obbiettivo dell’accordo prevede il consolidamento delle attività di produzione...

30

Nov

ICH recaps progress made over past year, charts new topics

The International Council for Harmonisation (ICH) announced that “significant milestones”...

25

Nov

UE: Parlamento, proposte per farmaci più accessibili e convenienti

I deputati europei hanno avanzato proposte per rendere i farmaci più accessibili e convenienti,...

slider-banner

h-footer